====== Opportunity Pool-supported Administrative Supplements (OPAS) ======

<font small/inherit;;inherit;;inherit><font inherit/inherit;;#222222;;inherit><font inherit/Arial, Helvetica, sans-serif;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;#ffffff><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;initial;;inherit><font inherit/inherit;;inherit;;inherit>The NIH 4DN Working Group and the NIH Common Fund Office have decided to support new 1-yr research or tool-development proposals that address outstanding challenges related to 4DN’s mission. These new projects will be funded through Opportunity Pool-supported Administrative Supplements (OPAS) to existing 4DN awards. The attached announcement describes the research areas open to support and the OPAS application process. The related timeline is as follows:</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>

  * <font small/inherit;;inherit;;inherit><font inherit/inherit;;#222222;;inherit><font inherit/Arial, Helvetica, sans-serif;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;#ffffff><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;initial;;inherit>Before April 5<sup>th</sup>   , 2019 Submit short LOI and discuss OP concept with Program Staff</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>
  * <font small/inherit;;inherit;;inherit><font inherit/inherit;;#222222;;inherit><font inherit/Arial, Helvetica, sans-serif;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;#ffffff><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;initial;;inherit>April 22<sup>nd</sup>   , 2019 Deadline for application</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>
  * <font small/inherit;;inherit;;inherit><font inherit/inherit;;#222222;;inherit><font inherit/Arial, Helvetica, sans-serif;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;#ffffff><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;initial;;inherit>May 10<sup>th</sup>   , 2019 NIH-approved funding plan</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>
  * <font small/inherit;;inherit;;inherit><font inherit/inherit;;#222222;;inherit><font inherit/Arial, Helvetica, sans-serif;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;#ffffff><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;initial;;inherit>Early June, 2019 Issuance of Administrative Supplements</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>

<font small/Arial, Helvetica, sans-serif;;initial;;inherit>[[https://drive.google.com/open?id=0B1Uh14Y8H75dcDV2dzlaNjdlaXE1d0NoREZXaVA3ZnFRYXJr|OPAS application information]]</font>

<font small/inherit;;inherit;;inherit><font inherit/inherit;;#222222;;inherit><font inherit/Arial, Helvetica, sans-serif;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;#ffffff><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;initial;;inherit>Do not hesitate to contact me via email with any questions that you may have about this opportunity.</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>

<font small/inherit;;inherit;;inherit><font inherit/inherit;;#222222;;inherit><font inherit/Arial, Helvetica, sans-serif;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;#ffffff><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;initial;;inherit>Best,</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>

<font small/inherit;;inherit;;inherit><font inherit/inherit;;#222222;;inherit><font inherit/Arial, Helvetica, sans-serif;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;#ffffff><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;initial;;inherit>Olivier Blondel, NIDDK</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>

<font small/inherit;;inherit;;inherit><font inherit/inherit;;#222222;;inherit><font inherit/Arial, Helvetica, sans-serif;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;#ffffff><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;initial;;inherit>Co-coordinator, 4DN Program</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>

<font small/inherit;;inherit;;inherit><font inherit/inherit;;#222222;;inherit><font inherit/Arial, Helvetica, sans-serif;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;inherit;;#ffffff><font inherit/inherit;;inherit;;inherit><font inherit/inherit;;initial;;inherit>On behalf of the NIH 4DN Working Group</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>

------------------------------------------------------------------------------------------

{{medialist>4dn:4dn_opportunity_funds:opas:}}